These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25003198)

  • 1. The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells.
    Yao X; Jennings S; Ireland SK; Pham T; Temple B; Davis M; Chen R; Davenport I; Biliran H
    PLoS One; 2014; 9(7):e101564. PubMed ID: 25003198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
    Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
    PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells.
    Brunquell C; Biliran H; Jennings S; Ireland SK; Chen R; Ruoslahti E
    Mol Cancer Res; 2012 Nov; 10(11):1482-95. PubMed ID: 22952044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin.
    Yao X; Gray S; Pham T; Delgardo M; Nguyen A; Do S; Ireland SK; Chen R; Abdel-Mageed AB; Biliran H
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1240-1248. PubMed ID: 29170133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis of tumor cells is enhanced by downregulation of Bit1.
    Karmali PP; Brunquell C; Tram H; Ireland SK; Ruoslahti E; Biliran H
    PLoS One; 2011; 6(8):e23840. PubMed ID: 21886829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase D is a positive regulator of Bit1 apoptotic function.
    Biliran H; Jan Y; Chen R; Pasquale EB; Ruoslahti E
    J Biol Chem; 2008 Oct; 283(42):28029-37. PubMed ID: 18703509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors.
    Jan Y; Matter M; Pai JT; Chen YL; Pilch J; Komatsu M; Ong E; Fukuda M; Ruoslahti E
    Cell; 2004 Mar; 116(5):751-62. PubMed ID: 15006356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
    Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anoikis effector Bit1 negatively regulates Erk activity.
    Kairouz-Wahbe R; Biliran H; Luo X; Khor I; Wankell M; Besch-Williford C; Pascual J; Oshima R; Ruoslahti E
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1528-32. PubMed ID: 18218778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bit1 in anoikis resistance and tumor metastasis.
    Jenning S; Pham T; Ireland SK; Ruoslahti E; Biliran H
    Cancer Lett; 2013 Jun; 333(2):147-51. PubMed ID: 23376255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLE1 inhibits anoikis and promotes tumorigenicity in human lung cancer cells through ZEB1-mediated E-cadherin repression.
    Yao X; Pham T; Temple B; Gray S; Cannon C; Hardy C; Fletcher K; Ireland SK; Hossain A; Chen R; Abdel-Mageed AB; Biliran H
    Oncotarget; 2017 Sep; 8(42):72235-72249. PubMed ID: 29069783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a proapoptotic peptide to intratumorally spreading cancer therapy.
    Chen R; Braun GB; Luo X; Sugahara KN; Teesalu T; Ruoslahti E
    Cancer Res; 2013 Feb; 73(4):1352-61. PubMed ID: 23248118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against human bit1, an apoptosis-associated mitochondrial protein.
    Hua W; Chen B; Zhang W; Miao S; Zhang H; Xin X
    Hybridoma (Larchmt); 2009 Jun; 28(3):167-71. PubMed ID: 19519243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the apoptosis-inducing factor or Bcl-2 inhibitor of transcription by RNA interference can alleviate TAp63gamma-induced apoptosis in esophageal squamous carcinoma EC9706 cells.
    Fan T; Jiang G; Suo Z; Liu H; Xu P; Ji Z; Zhang L; Yang G
    Int J Oncol; 2009 Aug; 35(2):359-67. PubMed ID: 19578750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological implication and function of Bcl2-inhibitor of transcription in ovarian serous papillary adenocarcinomas.
    Hua W; Miao S; Zou W; Yang H; Chen BL
    Neoplasma; 2013; 60(2):143-50. PubMed ID: 23259782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways.
    Bouchentouf M; Benabdallah BF; Rousseau J; Schwartz LM; Tremblay JP
    Am J Transplant; 2007 Jun; 7(6):1491-505. PubMed ID: 17511679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic ras-induced down-regulation of pro-apoptotic protease caspase-2 is required for malignant transformation of intestinal epithelial cells.
    Yoo BH; Wang Y; Erdogan M; Sasazuki T; Shirasawa S; Corcos L; Sabapathy K; Rosen KV
    J Biol Chem; 2011 Nov; 286(45):38894-903. PubMed ID: 21903589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen decreases anoikis of ovarian cancer cell line Caov-3 through reducing release of Bit1.
    Zheng J; Zhou J; Xie X; Xie B; Lin J; Xu Z; Zhang W
    DNA Cell Biol; 2014 Dec; 33(12):847-53. PubMed ID: 25211327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-suppression function of KLF12 through regulation of anoikis.
    Godin-Heymann N; Brabetz S; Murillo MM; Saponaro M; Santos CR; Lobley A; East P; Chakravarty P; Matthews N; Kelly G; Jordan S; Castellano E; Downward J
    Oncogene; 2016 Jun; 35(25):3324-34. PubMed ID: 26455320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.